SynthesisResearch on child and adolescent psychopathology2026
The Efficacy of Acceptance and Commitment Therapy for Reducing Anxiety in Parents of Children With Special Needs: A Meta-Analysis.
Synthesis in Research on child and adolescent psychopathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parents of children with special needs often face persistent mental health challenges. Acceptance and Commitment Therapy (ACT) has shown promise via the psychological flexibility framework, but reported effects have been heterogeneous. We systematically searched PubMed, Web of Science, and the Cochrane Library for randomized controlled trials of ACT delivered to parents of children with special needs that reported standardized effect sizes for parental anxiety. Eleven studies (n = 768) met the inclusion criteria. A fixed-effects meta-analysis revealed that ACT significantly alleviated parental anxiety symptoms (standardized mean difference (SMD) = - 0.26; 95% CI - 0.40 to - 0.12; P = 0.0003). Subgroup analyses indicated that the most substantial effects were observed among parents of children with neurodevelopmental disorders (SMD = - 0.50). Interventions conducted four times a week, lasting 120 min per session over 6-8 weeks, resulted in more pronounced effects (SMD = - 0.42). Integrated intervention approaches also produced positive results (SMD = - 0.35). Meta-regression analysis highlighted mean parent age and child condition as key moderators; studies involving parents of children with neurodevelopmental disorders exhibited greater effects (β = -0.37, p = 0.021), while each additional year of parent age correlated with a 0.05-unit increase in SMD (indicating a slightly reduced treatment effect). In summary, ACT seems effective in reducing parental anxiety symptoms among parents of children with special needs, with the most significant advantages noted in high-frequency/high-intensity standardized programs and among those caring for children with neurodevelopmental disorders.
Indexed as
Identifiers
41636923What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.